Oxaliplatin|containing adjuvant chemotherapy improves the survival ...

Oxaliplatin-containing adjuvant chemotherapy improves the survival ...

Oxaliplatin-containing ACT may confer survival benefits to patients with pCR, particularly younger patients. However, the routine use of ACT in patients ...

Oxaliplatin-containing adjuvant chemotherapy improves the survival ...

Oxaliplatin-containing adjuvant chemotherapy improves the survival of locally advanced rectal cancer patients with pathological complete response after pre- ...

Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for ...

The standard adjuvant treatment of colon cancer is fluorouracil plus leucovorin (FL). Oxaliplatin improves the efficacy of this combination in patients with ...

Improved Overall Survival With Oxaliplatin, Fluorouracil, and ...

Adding oxaliplatin to LV5FU2 significantly improved 5-year DFS and 6-year OS in the adjuvant treatment of stage II or III colon cancer.

Adjuvant chemotherapy is associated with improved survival in ...

Improved OS was found to be associated with adjuvant chemotherapy regardless of treatment regimen, patient age, or high-risk pathologic risk features.

Improved survival with adjuvant chemotherapy in locally advanced ...

In the pCR group, five-year survival probability was 87% (95% CI 84%–89%) with adjuvant therapy and 81% (95% CI 79%–82%) without adjuvant therapy. In the non- ...

Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and ...

Addition of oxaliplatin to fluoropyrimidine-based adjuvant regimens administered over a 6-month period improves disease-free survival (DFS) and overall survival ...

Association Between Adjuvant Chemotherapy Duration and Survival ...

However, among studies of adjuvant monotherapy, 6 months of chemotherapy was associated with improved overall survival relative to 3 months (HR, ...

Oxaliplatin-Based Adjuvant Chemotherapy without Radiotherapy ...

Adjuvant oxaliplatin-containing chemotherapy can improve the survival of patients with locally-advanced low and middle rectal cancers in comparison with ...

Adjuvant chemotherapy with oxaliplatin, in combination with ...

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival but increases adverse events compared ...

Survival outcomes associated with completion of adjuvant ...

Completion of all cycles of chemotherapy was associated with improved cancer-specific survival in real-world practice.

[PDF] Improved overall survival with oxaliplatin, fluorouracil, and ...

Adding oxaliplatin to LV5FU2 significantly improved 5-year DFS and 6-year OS in the adjuvant treatment of stage II or III colon cancer and should be ...

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

Among patients with cancers that were classified as T4, N2, or both, the disease-free survival rate for a 6-month duration of therapy was ...

Making sense of adjuvant chemotherapy in colorectal cancer - Chan

The study demonstrated improved survival and decreased recurrence from adjuvant chemotherapy with 5-FU and levamisole administered for 12 months after surgery ...

Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in ...

The patients receiving oxaliplatin-based chemotherapy also showed no significant increase in the slopes (per half-year) of the three-year ...

Adjuvant Chemotherapy - an overview | ScienceDirect Topics

While most of the clinical trials do not support the contention that adjuvant chemotherapy may improve survival outcomes if pre-operative (chemo)radiotherapy is ...

The influence of adjuvant chemotherapy dose intensity on overall ...

and oxaliplatin based adjuvant chemotherapy for resected colon cancer ... chemotherapy agent, is associated with improved overall survival.

Adjuvant Therapy for Stage III Colon Cancer - The ASCO Post

“The association between oxaliplatin treatment and better survival was maintained in older and minority group patients, as well as those with ...

Adjuvant chemotherapy does not provide survival benefits to elderly ...

Adjuvant chemotherapy does not appear to yield survival benefits in elderly patients with stage II colon cancer.

Effects of oxaliplatin-containing adjuvant chemotherapy on shortterm ...

Adjuvant chemotherapy for high risk stages II and III colon cancer is recommended to eliminate micrometastases and, thus, improve patient's survival after ...